TruBridge (NASDAQ:TBRG) Insider Buys $50,375.00 in Stock

TruBridge, Inc. (NASDAQ:TBRG) insider Michael Daughton acquired 2,500 shares of the business’s stock in a transaction on Friday, November 14th. The stock was acquired at an average price of $20.15 per share, with a total value of $50,375.00. Following the transaction, the insider directly owned 39,992 shares of the company’s stock, valued at $805,838.80. This represents a 6.67% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Michael Daughton also recently made the following trade(s):

• On Monday, November 17th, Michael Daughton purchased 17,500 shares of TruBridge stock. The shares were bought at an average cost of $20.46 per share, for a total transaction of $358,050.00.
• On Thursday, November 13th, Michael Daughton purchased 4,354 shares of TruBridge stock. The stock was bought at an average price of $20.16 per share, with a total value of $87,776.64.
• On Wednesday, November 12th, Michael Daughton acquired 10,167 shares of TruBridge stock. The shares were bought at an average cost of $19.95 per share, for a total transaction of $202,831.65.
• On Tuesday, November 11th, Michael Daughton bought 15,479 shares of TruBridge stock. The shares were bought at an average price of $19.39 per share, for a total transaction of $300,137.81.

TruBridge Price Performance

TBRG stock opened at $21.00 on Friday. The firm has a 50 day moving average of $20.15 and a 200-day moving average of $21.59. TruBridge, Inc. has a 12-month low of $15.69 and a 12-month high of $32.00. The company has a current ratio of 1.80, a quick ratio of 1.79 and a debt-to-equity ratio of 0.94. The company has a market cap of $315.19 million, a price-to-earnings ratio of -25.00 and a beta of 0.57.

TruBridge (NASDAQ:TBRG) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.48. The business had revenue of $86.11 million for the quarter, compared to analysts’ expectations of $85.56 million. TruBridge had a positive return on equity of 3.30% and a negative net margin of 3.63%. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts expect that TruBridge, Inc. will post 0.07 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on TBRG. BMO Capital Markets began coverage on TruBridge in a research note on Thursday, November 13th. They set a “market perform” rating and a $19.50 price target for the company. Weiss Ratings restated a “sell (e+)” rating on shares of TruBridge in a research report on Friday, October 31st. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, TruBridge currently has a consensus rating of “Hold” and a consensus price target of $25.50.

Hedge Funds Weigh In On TruBridge

Several hedge funds and other institutional investors have recently bought and sold shares of TBRG. Legal & General Group Plc acquired a new stake in TruBridge during the 2nd quarter valued at approximately $26,000. First Horizon Corp bought a new stake in TruBridge in the third quarter valued at $42,000. Police & Firemen s Retirement System of New Jersey bought a new position in TruBridge in the 2nd quarter worth approximately $59,000. New York State Common Retirement Fund acquired a new position in shares of TruBridge during the second quarter valued at $101,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of TruBridge during the 2nd quarter worth about $128,000. 88.64% of the stock is owned by institutional investors and hedge funds.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.